Cargando…

Economic Evaluation of Chelation Regimens for β-Thalassemia Major: a Systematic Review

BACKGROUND: Deferoxamine (DFO) or Deferiprone (DFP) or Deferasirox (DFX) monotherapy and DFO and DFP combination therapy (DFO+DFP) were four commonly implemented now chelation regimens for the iron overloaded of β-thalassemia major. This systematic review aims to determine the cost-effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jialian, Lin, Yong, Li, Xue, Zhang, Jiayou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613630/ https://www.ncbi.nlm.nih.gov/pubmed/31308912 http://dx.doi.org/10.4084/MJHID.2019.036

Ejemplares similares

Cost-Utility Analysis of four Chelation Regimens for β-thalassemia Major: a Chinese Perspective
por: Li, Jialian, et al.
Publicado: (2020)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

Cardiac Function and Iron Chelation in Thalassemia Major and Intermedia: a Review of the Underlying Pathophysiology and Approach to Chelation Management
por: Aessopos, Athanasios, et al.
Publicado: (2009)

Successful chelation in beta-thalassemia major in the 21(st) century
por: Fragodimitri, Christina, et al.
Publicado: (2023)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Sensorineural Hearing Loss and Its Relationship with Duration of Chelation Among Major β-Thalassemia Patients
por: Khan, Muhammad Ali, et al.
Publicado: (2019)

Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
por: Tanous, Osama, et al.
Publicado: (2021)

Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
por: Zarghamian, Parinaz, et al.
Publicado: (2020)

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β-THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW
por: Piga, A., et al.
Publicado: (2022)

Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated
por: Meloni, Antonella, et al.
Publicado: (2015)

Efficacy and adverse effects of oral chelating therapy (deferasirox) in multi-transfused Pakistani children with β-thalassemia major
por: Ejaz, Muzamil Shabana, et al.
Publicado: (2015)

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017)

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy
por: Meloni, Antonella, et al.
Publicado: (2022)

Major Thalassemia, Screening or Treatment: An Economic Evaluation Study in Iran
por: Esmaeilzadeh, Firooz, et al.
Publicado: (2021)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
por: Eziefula, Chinea, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis of Stature Growth Complications in β-thalassemia Major Patients
por: Arab-Zozani, Morteza, et al.
Publicado: (2021)

On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
por: Pennell, DJ, et al.
Publicado: (2011)

Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major
por: Nuzzi, Raffaele, et al.
Publicado: (2021)

Nutritional studies in patients with β-thalassemia major: A short review
por: Soliman, Ashraf, et al.
Publicado: (2023)

Evaluation of Optical Coherence Tomography Findings and Choroidal Thickness in Beta-Thalassemia Major Patients Using Chelation Therapy
por: Bayramoglu, Sadik Etka, et al.
Publicado: (2022)

Economic Burden of Thalassemia Major in Iran, 2015
por: Esmaeilzadeh, Firooz, et al.
Publicado: (2016)

A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia
por: Reddy, Paavani S., et al.
Publicado: (2022)

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
por: Origa, Raffaella, et al.
Publicado: (2022)

Beliefs about chelation among thalassemia patients
por: Trachtenberg, Felicia L, et al.
Publicado: (2012)

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
por: Romadhon, Pradana Zaky, et al.
Publicado: (2022)

Serum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor
por: Işık Balcı, Yasemin, et al.
Publicado: (2016)

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
por: Tanner, Mark A, et al.
Publicado: (2008)

Molecular Aspects of Bone Resorption in β-Thalassemia Major
por: Saki, Najmaldin, et al.
Publicado: (2015)

Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe β-Thalassemia
por: Susanah, Susi, et al.
Publicado: (2020)

Therapeutic potential of silymarin as a natural iron‐chelating agent in β‐thalassemia intermedia
por: Reisi, Nahid, et al.
Publicado: (2022)

Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children
por: Riewpaiboon, Arthorn, et al.
Publicado: (2010)

Comment on: "Economic Burden of Thalassemia Major in Iran, 2015"
por: Rezaei, Satar, et al.
Publicado: (2016)

Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
por: Hamed, Enas A, et al.
Publicado: (2010)

Thalassemia Major in Adults: Short Stature, Hyperpigmentation, Inadequate Chelation, and Transfusion-Transmitted Infections are Key Features
por: Prakash, Anupam, et al.
Publicado: (2012)

Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review
por: Mulas, Olga, et al.
Publicado: (2022)

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
por: Saliba, Antoine N, et al.
Publicado: (2015)

MRI Evaluation of Liver Iron Concentration in Patients with β-Thalassemia Major
por: Karimi, M, et al.
Publicado: (2010)

Hyperhemolysis in a patient with β-thalassemia major
por: Morawakage, Lakmali R., et al.
Publicado: (2009)

Hypogonadism in thalassemia major patients
por: Srisukh, Sasima, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0lrq3uhnl2ttphiugut5o0v7mv